Melanoma Journal Articles for March 2018
CANCER DISCOVERY
Research Watch
Patients with Desmoplastic Melanoma May Respond to PD-1 Blockade
DOI: 10.1158/2159-8290.CD-RW2018-012 Published March 2018
Dove Press
Co-delivery of Aurora-A inhibitor XY-4 and Bcl-xl siRNA enhances antitumor efficacy for melanoma therapy
Authors Duan X, Mu M, Yan J, Bai L, Zhong L, Zhu Y, Pan H, Zhang M, Shi J
Received 30 July 2017
Accepted for publication 7 December 2017
Published 9 March 2018 Volume 2018:13 Pages 1443—1456
DOI https://doi.org/10.2147/IJN.S147759
American Chemical Society Nano
Copper Silicate Hollow Microspheres-Incorporated Scaffolds for Chemo-Photothermal Therapy of Melanoma and Tissue Healing
Qingqing Yu†‡?, Yiming Han§?, Xiaocheng Wang†‡, Chen Qin†‡, Dong Zhai†, Zhengfang Yi*§, Jiang Chang† , Yin Xiao?, and Chengtie Wu
DOI: 10.1021/acsnano.7b08928
Publication Date (Web): March 8, 2018
Neoadjuvant treatment for malignant and metastatic cutaneous melanoma.
Gorry C, McCullagh L, O’Donnell H, Barrett S, Schmitz S, Barry M, Curtin K, Beausang E, Barry R, Coyne I.
Cochrane Database of Systematic Reviews 2018, Issue 3. Art. No.: CD012974. DOI: 10.1002/14651858.CD012974.
Sci Rep. 2018 Mar 7;8(1):4111. doi: 10.1038/s41598-018-22484-6.
Down-regulation of GADD45A enhances chemosensitivity in melanoma.
Liu J1, Jiang G1, Mao P2, Zhang J1, Zhang L3, Liu L1, Wang J1, Owusu L4, Ren B1, Tang Y5, Li W6.
The European Journal of Health Economics
The cost-effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England
Yang Meng, Nadine Hertel, John Ellis, Edith Morais, Helen Johnson, Zoe Philips, Neil Roskell, Andrew Walker, Dawn Lee
First Online: 09 March 2018
DOIhttps://doi.org/10.1007/s10198-018-0964-4
JNCI
Risk Stratification for Melanoma: Models Derived and Validated in a Purpose-Designed Prospective Cohort
Catherine M Olsen Nirmala Pandeya Bridie S Thompson Jean Claude DusingizePenelope M Webb Adele C Green Rachel E Neale David C Whiteman for the QSkin Study
JNCI: Journal of the National Cancer Institute,
https://doi.org/10.1093/jnci/djy023
Published: 11 March 2018
The prognostic significance of tumor-infiltrating lymphocytes for primary melanoma varies by sex.
Sinnamon AJ, Sharon CE, Song Y, et al.
[Published online ahead of print March 5, 2018].
J Am Acad Dermatol. doi:10.1016/j.jaad.2018.02.066.
Cureus
Case report
Subungual Amelanotic Melanoma Masquerading as Onychomycosis
Ryan R. Riahi , Philip R. Cohen, Leonard H. Goldberg
Published: March 11, 2018 (see history)
DOI: 10.7759/cureus.2307
Dove Press
Modulation of human melanoma cell proliferation and apoptosis by hydatid cyst fluid of Echinococcus granulosus
Authors Gao X, Zhang G, Huang L
Received 13 July 2017
Accepted for publication 31 October 2017
Published 15 March 2018 Volume 2018:11 Pages 1447—1456
DOI https://doi.org/10.2147/OTT.S146300
Journal of Interferon & Cytokine ResearchVol. 23, No. 10
Increased Interleukin-10 mRNA Stability in Melanoma Cells Is Associated with Decreased Levels of A + U-Rich Element Binding Factor AUF1
Gary Brewer, Simona Saccani, Srijata Sarkar, Anita Lewis, Sidney Pestka
Published Online:7 Jul 2004
https://doi.org/10.1089/107999003322485053
Investigation and Stimulation of Immunity in Cancer Patients pp 476-485
BCG Stimulation of Immune Responsiveness in Patients with Malignant Melanoma
- U. Gutterman, G. Mavligit, Ch. M. McBride, E. FreiIII., E. M. Hersh
Conference paper
Part of the Recent Results in Cancer Research book series (RECENTCANCER, volume 47)
Dove Press
Upregulation of FOXP1 is a new independent unfavorable prognosticator and a specific predictor of lymphatic dissemination in cutaneous melanoma patients
Authors Donizy P, Pagacz K, Marczuk J, Fendler W, Maciejczyk A, Halon A, Matkowski R
Received 9 September 2017
Accepted for publication 5 December 2017
Published 14 March 2018 Volume 2018:11 Pages 1413—1422
DOI https://doi.org/10.2147/OTT.S151286
Journal of Clinical Oncology
Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)
Richard D. Carvajal, Sophie Piperno-Neumann, Ellen Kapiteijn, Paul B. Chapman, Stephen Frank, Anthony M. Joshua, Josep M. Piulats, Pascal Wolter, Veronique Cocquyt, Bartosz Chmielowski, T.R. Jeffry Evans, Lauris Gastaud, Gerald Linette, Carola Berking, Jacob Schachter, Manuel J. Rodrigues, Alexander N. Shoushtari, Delyth Clemett, Dana Ghiorghiu, Gabriella Mariani, Shirley Spratt, Susan Lovick, Peter Barker, Elaine Kilgour, Zhongwu Lai, Gary K. Schwartz, and Paul Nathan
DOI: 10.1200/JCO.2017.74.1090 Journal of Clinical Oncology – published online before print March 12, 2018
PMID: 29528792
Oncology Letters
Targeted silencing of the ADP-ribosyltransferase 3 gene inhibits the migration ability of melanoma cells
Jie He, Yongyun Li, Ying Wang, He Zhang, Shengfang Ge, Xianqun Fan
Published online on: March 13, 2018 https://doi.org/10.3892/ol.2018.825
JAMA Dematology
Accuracy of Dermoscopic Criteria for the Diagnosis of Melanoma In Situ
Aimilios Lallas, PhD1; Caterina Longo, PhD2; Marco Manfredini, MD3; et alElisa Benati, MD2; Graziella Babino, MD4; Chiara Chinazzo, MD4; Zoe Apalla, PhD1; Chryssoula Papageorgiou, MD1; Elvira Moscarella, MD4; Athanassios Kyrgidis, PhD2; Giuseppe Argenziano, PhD4
JAMA Dermatol. Published online February 21, 2018. doi:10.1001/jamadermatol.2017.6447
Oncology Times
The Reality of Precision Medicine in Metastatic Melanoma
Weber, Jeffrey S. MD, PhD
Oncology Times: March 20, 2018 – Volume 40 – Issue 6 – p 1–5
doi: 10.1097/01.COT.0000531929.16181.f4
Pigment Cell & Melanoma Research
The potent pro?oxidant activity of rhododendrol–eumelanin is enhanced by ultraviolet A radiation
Shosuke Ito, Misa Agata, Kotono Okochi, Kazumasa Wakamatsu
First published: 12 March 2018
https://doi.org/10.1111/pcmr.12696
Nature Medicine
Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors.
Boshuizen J, Koopman LA, Krijgsman O, Shahrabi A, van den Heuvel EG, Ligtenberg MA, Vredevoogd DW, Kemper K, Kuilman T, Song JY, Pencheva N, Mortensen JT, Foppen MG, Rozeman EA, Blank CU,Janmaat ML, Satijn D, Breij ECW, Peeper DS, Parren PWHI
show author affiliations
Nat Med. 2018 Feb; 24(2):203-212
Cancer Research
Krüger-Krasagakes S., Krasagakis K., Garbe C., Diamantstein T. (1995) Production of Cytokines by Human Melanoma Cells and Melanocytes. In: Garbe C., Schmitz S., Orfanos C.E. (eds) Skin Cancer: Basic Science, Clinical Research and Treatment. Recent Results in Cancer Research, vol 139. Springer, Berlin, Heidelberg
DOIhttps://doi.org/10.1007/978-3-642-78771-3_11
Publisher Name Springer, Berlin, Heidelberg
Print ISBN978-3-642-78773-7
Online ISBN978-3-642-78771-3
Clinical Cancer Research
Cancer Therapy: Preclinical
Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma
Gao Zhang, Lawrence W Wu, ilgen Mender, Michal Barzily-Rokni, Marc R. Hammond, Omotayo Ope, Chaoran Cheng, Sergio Randell, Norah Sadek, Aurelie Beroard, Min Xiao, Tian Tian, Jiufeng Tan, Umar Saeed, Eric Sugarman, Clemens Krepler, Patricia A Brafford, Katrin Sproesser, Sengottuvelan Murugan, Rajasekharan Somasundaram, Bradley Garman, Bradley Wubbenhorst, Jonathan Woo, Xiangfan Yin, Qin Liu, Dennie T Frederick, Benchun Miao, Wei Xu, Giorgos C Karakousis, Xiaowei Xu, Lynn M. Schuchter, Tara C. Mitchell, Lawrence N. Kwong, Ravi K. Amaravadi, Yiling Lu, Genevieve Boland, Zhi Wei, Katherine L. Nathanson, Gordon B. Mills, Keith T. Flaherty, Jerry W Shay, Meenhard Herlyn, Themistoklis Vasilopoulos and Utz Herbig
DOI: 10.1158/1078-0432.CCR-17-2773
BOOK: Epidemiology of Malignant Melanoma
Tucker M.A., Hartge P., Shields J.A. (1986) Epidemiology of Intraocular Melanoma. In: Gallagher R.P. (eds) Epidemiology of Malignant Melanoma. Recent Results in Cancer Research, vol 102. Springer, Berlin, Heidelberg
DOIhttps://doi.org/10.1007/978-3-642-82641-2_14
Publisher Name Springer, Berlin, Heidelberg
Print ISBN978-3-642-82643-6
Online ISBN978-3-642-82641-2
Rechallenge With Nivolumab After Vemurafenib Treatment of Initially Nivolumab-Resistant Advanced Melanoma
Junji Kato, MD1; Tokimasa Hida, MD, PhD1; Takafumi Kamiya, MD, PhD1; et alSayuri Sato, MD1; Hitomi Takahashi, MD1; Toshihiko Torigoe, MD, PhD2; Hisashi Uhara, MD, PhD1
JAMA Dermatol. Published online March 28, 2018. doi:10.1001/jamadermatol.2017.6400
JNCI: Journal of the National Cancer Institute,
Melanoma Screening and Mortality
David E Elder
djy056,https://doi.org/10.1093/jnci/djy056
Published: 29 March 2018
PD-L1–Independent Mechanisms Control the Resistance of Melanoma to CD4+ T Cell Adoptive Immunotherapy
Stephen R. Goding, Kyle A. Wilson, Carolyn Rosinsky and Paul Andrew Antony
J Immunol March 30, 2018, ji1701617; DOI: https://doi.org/10.4049/jimmunol.1701617
Oncology Reports
Critical role for non GAP function of G?s in RGS1 mediated promotion of melanoma progression through AKT and ERK phosphorylation
Meng Yan Sun, Yuchong Wang, Ji Zhu, Chuan Lv, Kai Wu, Xin Wei Wang, Chun Yu Xue
Published online on: March 30, 2018 https://doi.org/10.3892/or.2018.6341